QA: Moonlake Immunotherapeutics in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821586_2025_Moonlake_Immunotherapeutics.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001821586, Moonlake Immunotherapeutics

  xvar xval
0 AssetsCurrent 474,288,845
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 722,226
3 remainder_Assets 2,922,211
4 LiabilitiesCurrent 22,463,861
5 LiabilitiesNoncurrent 2,078,282
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,319,780
9 ResearchAndDevelopmentExpense 112,771,302
10 remainder_Expenses 282,199
11 remainder_Revenues 22,128,881
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 4,861,253
  yvar yval
0 Assets 477,933,282
1 Liabilities 24,542,143
2 Expenses 143,373,281
3 Revenues 22,128,881
4 StockholdersEquity 453,391,139
5 NetIncome -121,244,400
6 ComprehensiveNetIncome -118,813,774
7 BaseVar 336,419,420
8 EconomicCapitalRatiobeforeLimitedLiability 3.46
9 EconomicCapitalRatio 4.00

Edgar->Model Mapping

Feature Distribution

Change over Time